Total Payments
$2,417
2023 Payments
$21.06
Companies
9
Transactions
25
Medicare Patients
2,444
Medicare Billing
$488,370
Payment Breakdown by Category
Food & Beverage$1,286 (53.2%)
Travel$1,131 (46.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,286 | 23 | 53.2% |
| Travel and Lodging | $1,131 | 2 | 46.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $1,277 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $268.33 | 10 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $249.96 | 4 | $0 (2023) |
| Medtronic, Inc. | $186.07 | 1 | $0 (2022) |
| CVRx, Inc. | $149.17 | 1 | $0 (2020) |
| Respicardia, Inc. | $138.24 | 1 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $124.79 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $14.43 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.06 | 1 | Novartis Pharmaceuticals Corporation ($21.06) |
| 2022 | $186.07 | 1 | Medtronic, Inc. ($186.07) |
| 2021 | $138.69 | 8 | Janssen Pharmaceuticals, Inc ($138.69) |
| 2020 | $296.41 | 3 | CVRx, Inc. ($149.17) |
| 2019 | $114.49 | 1 | Novartis Pharmaceuticals Corporation ($114.49) |
| 2018 | $267.17 | 5 | Janssen Pharmaceuticals, Inc ($129.64) |
| 2017 | $1,393 | 6 | BIOTRONIK INC. ($1,154) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $186.07 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $105.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2020 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | In-kind items and services | $149.17 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/23/2020 | Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $138.24 | General |
| Category: Respiratory | ||||||
| 09/18/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/18/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $114.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2018 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $59.18 | General |
| 06/12/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/22/2018 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $63.92 | General |
| 11/21/2017 | BIOTRONIK INC. | — | Travel and Lodging | In-kind items and services | $603.05 | General |
| 11/16/2017 | BOSTON SCIENTIFIC CORPORATION | SYNERGY (Device) | Food and Beverage | In-kind items and services | $124.79 | General |
| Category: STENTS | ||||||
| 11/07/2017 | BIOTRONIK INC. | — | Travel and Lodging | Cash or cash equivalent | $528.08 | General |
| 10/20/2017 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 07/26/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $109.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 580 | 1,373 | $188,540 | $129,091 |
| 2022 | 8 | 666 | 1,536 | $187,983 | $130,810 |
| 2021 | 7 | 563 | 1,315 | $155,560 | $110,188 |
| 2020 | 8 | 635 | 1,356 | $163,744 | $118,281 |
Total Patients
2,444
Total Services
5,580
Medicare Billing
$488,370
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 273 | 959 | $124,270 | $87,933 | 70.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 99 | $22,352 | $13,261 | 59.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 129 | 129 | $16,224 | $11,320 | 69.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 28 | 132 | $16,500 | $10,804 | 65.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 23 | 25 | $4,850 | $3,324 | 68.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $3,024 | $1,808 | 59.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 11 | 11 | $1,320 | $640.64 | 48.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 305 | 1,111 | $122,210 | $87,850 | 71.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 122 | 125 | $26,875 | $18,871 | 70.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 168 | 170 | $20,400 | $13,809 | 67.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 11 | 67 | $8,375 | $4,658 | 55.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $2,938 | $1,692 | 57.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 12 | 12 | $2,065 | $1,519 | 73.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 24 | 24 | $2,880 | $1,313 | 45.6% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 11 | 14 | $2,240 | $1,099 | 49.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 248 | 914 | $100,540 | $73,815 | 73.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 74 | 74 | $15,910 | $11,582 | 72.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 124 | 126 | $15,120 | $10,486 | 69.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 95 | $7,140 | $5,351 | 74.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 25 | 25 | $5,650 | $3,563 | 63.1% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 25 | 37 | $5,920 | $2,975 | 50.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 44 | 44 | $5,280 | $2,416 | 45.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 271 | 943 | $103,730 | $77,937 | 75.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 96 | 96 | $20,640 | $15,410 | 74.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 152 | 155 | $18,600 | $13,171 | 70.8% |
About Dr. Michael Alloway, DO
Dr. Michael Alloway, DO is a Internal Medicine healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083702583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Alloway, DO has received a total of $2,417 in payments from pharmaceutical and medical device companies, with $21.06 received in 2023. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,286).
As a Medicare-enrolled provider, Alloway has provided services to 2,444 Medicare beneficiaries, totaling 5,580 services with total Medicare billing of $488,370. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tucson, AZ
- Active Since 10/10/2006
- Last Updated 03/17/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083702583
Products in Payments
- XARELTO (Drug) $282.76
- ENTRESTO (Drug) $249.96
- INTERSTIM (Device) $186.07
- Barostim Neo System (Device) $149.17
- remede System (Device) $138.24
- SYNERGY (Device) $124.79
- LifeVest (Device) $9.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tucson
Dr. Rajesh Janardhanan, Md, Mrcp, Facc, Fase, MD, MRCP, FACC, FASE
Internal Medicine — Payments: $837,483
Internal Medicine $837,483
Steven Mottl, D.o, D.O
Internal Medicine — Payments: $317,974
Internal Medicine $317,974
Dr. Nebojsa Skrepnik, Md, MD
Internal Medicine — Payments: $315,594
Internal Medicine $315,594
Jyotsna Sahni, M.d, M.D
Internal Medicine — Payments: $150,501
Internal Medicine $150,501
Dr. Neil Gheewala, M.d, M.D
Internal Medicine — Payments: $145,873
Internal Medicine $145,873
Dr. Tara Carr, M.d, M.D
Internal Medicine — Payments: $117,865
Internal Medicine $117,865